Home » Topics » BioWorld

BioWorld
RSS

CYGNUS RAISES $25 MILLION IN IPO

Feb. 4, 1991

AMGEN, ENZON QUIT JOINT PEG EFFORT

Feb. 4, 1991

BIOREMEDIATION MAY SEE ACTION IN THE GULF

Feb. 4, 1991

PIM MOUSE SEEN AS BOON TO CARCINOGEN TESTS

Feb. 1, 1991

NEWS BRIEFS

Feb. 1, 1991

EARNINGS REPORTS

Feb. 1, 1991

PROPOSED COTTON TEST COMES UNDER FIRE

Feb. 1, 1991

ARRIS MARRIES MEDICINE AND COMPUTING

Feb. 1, 1991

APPOINTMENTS AND ADVANCEMENTS

Jan. 31, 1991

EARNINGS REPORTS

Jan. 31, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...